Kewaunee Scientific Reports 18% Increase in FY 2025 Sales; Net Earnings Per Share Jump to $1.70
Kewaunee Scientific Corporation reported strong financial results for fiscal year 2025, with sales reaching $240.5 million, marking an 18.0% increase compared to $203.8 million in the previous year. The company's net earnings for the year were $4.9 million, up from $4.6 million in the prior period. Operating profit saw a notable improvement, with $23.5 million recorded for fiscal 2025 compared to $18.3 million in the previous year. Earnings per share for the quarter ending April 30, 2024, showed positive results, with basic EPS at $1.70 for domestic operations and $0.34 for international operations. Kewaunee Scientific's President and CEO, Thomas D. Hull, III, highlighted the company's momentum in the market and its strategy of investing in the product portfolio and manufacturing assets. The company continues to focus on strengthening their dealer and distribution relationships, which has been a key driver for performance improvement. No specific guidance or outlook for the future was provided in the report.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kewaunee Scientific Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CL18552) on June 25, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.